Comprehensive Study Notes on Heart Failure and Cardiomyopathy

Cardiac Output and Tissue Damage

• Impact of Damage on Cardiac Function: Heart and muscle tissue that sustain damage cannot contract effectively. This leads to a reduction in cardiac output ($CO$). The risk of heart failure is directly proportional to the size of the damaged area.

• Co-morbidities: Obesity is closely associated with other conditions that stress the heart, including hypertension and diabetes.

• Dysrhythmias: Abnormal heart rhythms (dysrhythmias) reduce the efficiency of the heart and impair cardiac output by increasing the overall stress on the organ.

Risk Factors and Vascular Damage

• Smoking and Nicotine: Smoking causes vascular damage and decreases the delivery of oxygen ($O_2$). Nicotine specifically increases heart rate ($HR$) and blood pressure ($BP$), thereby increasing the workload of the heart.

• Structural Heart Issues: Problems with heart valves require the heart to work harder to move blood effectively. Over time, this increased workload can lead to ventricular dysfunction.

• Hypertension: Elevated systolic blood pressure increases vascular resistance.

• Lifestyle Factors: Limited physical activity and poor nutrition increase the risk of obesity, hypertension, diabetes, and cardiovascular disease.

Pathophysiology of Cardiomyopathy

• Definition: Cardiomyopathy is a primary condition leading to heart failure. Unlike vascular conditions, it is a problem specifically of the heart muscle itself (myocardium).

• Structural Changes: The myocardium becomes damaged, weakened, enlarged, stiff, or structurally abnormal. These changes reduce the heart's ability to pump blood effectively to the rest of the body.

Clinical Manifestations of Heart Failure

• Primary Causes of Symptoms: Most heart failure symptoms stem from two major issues:

  • Congestion: Caused by fluid buildup.

  • Poor Tissue Perfusion: Caused by decreased cardiac output ($CO$).

• Symptom Progression: Symptoms typically worsen gradually as cardiac functioning declines.

• Cardinal Manifestations:

  • Dyspnea: Shortness of breath is one of the earliest and most common symptoms. It occurs because blood backs up in circulation, causing fluid to accumulate.

  • Activity-Related Shortness of Breath: Patients report breathless during exertion.

  • Orthopnea: Difficulty breathing while lying flat. Patients may report needing to sleep with multiple pillows or sitting upright in a chair.

  • Paroxysmal Nocturnal Dyspnea (PND): Sudden episodes of severe shortness of breath during sleep, causing the patient to wake up gasping for air. This is a strong indicator of worsening pulmonary congestion.

  • Fatigue: Reduced cardiac output means tissues and muscles receive less oxygen, leading to low energy, weakness, and decreased ability to perform daily activities.

Left-Sided Heart Failure

• Primary Impact: Primarily affects the lungs because the left side of the heart backs up into pulmonary circulation.

• Mechanism: The left ventricle cannot effectively pump blood into systemic circulation, causing blood to back up into pulmonary vessels, impairing gas exchange.

• Assessment Findings:

  • Displaced Apical Pulse: Chronic left ventricular enlargement can shift the location of the apical pulse as the heart attempts to compensate for the workload.

  • $S_3$ Heart Sound: Also known as a "ventricular gallop." In adults, it is commonly associated with fluid overload and increased ventricular filling pressures.

  • Pulmonary Congestion Symptoms: Persistent cough (often worse when lying down), dyspnea, and bibasilar crackles (crackling sounds at the lung bases caused by fluid in the alveoli).

  • Frothy Sputum: Sputum that is frothy and may be blood-tinged indicates severe pulmonary congestion and is a concerning finding for pulmonary edema requiring immediate intervention.

  • Hypoxemia Indicators: Restlessness is an early sign of hypoxemia ($O_2$ deficiency in the blood).

Right-Sided Heart Failure

• Primary Impact: The right ventricle cannot pump blood effectively into the pulmonary circulation, causing blood to back up into the systemic venous system.

• Assessment Findings (Body Swelling):

  • Jugular Venous Distension (JVD): Increased venous pressure causes blood to back up into the jugular veins. This should be assessed with the patient positioned at an angle of $30$ to $45$ degrees.

  • Ascending Dependent Edema: Fluid accumulates in the ankles and legs (or the sacrum if bedbound) due to gravity.

  • Abdominal Distension and Ascites: Fluid accumulation in the abdominal cavity. Patients may report tight clothing, bloating, increased abdominal girth, nausea, and anorexia (loss of appetite) due to GI system congestion.

  • Hepatomegaly: Enlargement of the liver due to venous congestion in hepatic circulation. This can cause right upper quadrant ($RUQ$) discomfort and elevated liver function tests ($LFTs$).

  • Weight Gain: Rapid weight gain related to fluid retention rather than body fat. Daily weight is the best indicator of worsening heart failure.

  • Polyuria/Nocturia: Increased urination at night occurs because fluid from peripheral tissues returns to circulation when the patient is lying down, making it available for kidney filtration.

Nursing Assessment and Priority Actions

• Weight Monitoring: The priority nursing action for a patient with fatigue, dyspnea, tachycardia, and edema is to assess daily weight and compare it to their baseline.

• Assessing Breath Sounds: Hear failure crackles do not clear with coughing, unlike crackles caused by secretions. They are usually heard first at the lung bases.

• Mental Status: Decreased perfusion to the brain can lead to confusion, restlessness, forgetfulness, or altered mental status, especially in older adults.

• Skin Assessment: Cool, pale, or cyanotic extremities suggest that the body is redirecting blood to vital organs.

• Vital Signs: Tachycardia at rest is a compensatory mechanism to maintain perfusion under low cardiac output conditions.

Diagnostic Procedures and Laboratory Values

• B-type Natriuretic Peptide (BNP): Released when ventricles stretch due to increased pressure and fluid volume.

  • $BNP < 100$: Heart failure is unlikely.

  • $BNP$ between $100$ and $300$: Heart failure may be present.

  • $BNP > 300$: Indicates mild heart failure.

  • $BNP > 600$: Indicates moderate heart failure.

  • $BNP > 900$: Indicates severe heart failure and worsening congestion.

  • Note: Trends in $BNP$ (rising or falling) are more important than single levels for monitoring treatment response.

• Ejection Fraction (EF):

  • Normal: Up to $70\%$.

  • Concern: $EF < 40\%$, suggesting reduced systolic function.

• Transesophageal Echocardiogram (TEE): Uses an ultrasound probe in the esophagus to visualize heart structures and valves. Nursing priority involves monitoring electrolytes, specifically sodium ($Na^+$) and potassium ($K^+$) abnormalities.

Medical and Nursing Management of Heart Failure

• Management Goals: Improve cardiac output, reduce fluid overload, decrease myocardial stress, and improve the patient's functional status.

• Lifestyle and Dietary Modifications:

  • Sodium Restriction: Prevents volume overload.

  • Fluid Management: Restricting fluids as ordered.

  • Daily Weights: Perform first thing in the morning, wearing similar clothing, and use the same scale.

• Activity: Encourage bed rest during acute exacerbations to reduce oxygen demand. Gradually increase activity as symptoms improve. Use energy conservation (clustering activities) for patients who fatigue easily.

• Oxygen Therapy: Supports oxygenation but does not cure heart failure.

Pharmacological Interventions

• Diuretics (Reduce Preload):

  • Loop Diuretics (e.g., Furosemide): Strong agents for exacerbations to reduce pulmonary congestion. Monitor weight, I&O, blood pressure, and potassium ($K^+$) levels for hypokalemia.

  • Potassium-Sparing Diuretics (e.g., Spironolactone): Block aldosterone and conserve potassium. Monitor for hyperkalemia; patients should avoid salt substitutes containing potassium.

• Afterload Reducing Agents: Decrease the pressure the heart must push against.

  • ACE Inhibitors: Suffix "-pril." Improve outcomes and reduce hospitalization.

  • ARBs (Angiotensin II Receptor Blockers): Block angiotensin II at the receptor site; used if ACE inhibitors are not tolerated.

  • Calcium Channel Blockers: Relax blood vessels; use cautiously as some reduce contractility.

  • PDE-3 Inhibitors: Increase contractility and promote vasodilation; used for advanced heart failure.

  • Sildenafil: Used to reduce pulmonary vascular resistance and right-sided heart strain.

• Inotropes and Others:

  • Digoxin: Positive inotropic effect (increases contraction strength) and negative chronotropic effect (slows heart rate).

  • Beta Blockers: Block sympathetic nervous system ($SNS$) effects, lower heart rate, and reduce myocardial oxygen demand.

  • Vasodilators (e.g., Nitroglycerin): Reduce preload via venous dilation and afterload via arterial dilation.

Advanced Therapies

• Ventricular Assist Device (VAD): Used as a bridge to transplant, a bridge to recovery, or destination therapy (long-term support for those ineligible for transplant).

• Heart Transplant: Indicated for end-stage heart failure or severe dilated cardiomyopathy. Requires eligibility based on age, overall health, and commitment to lifelong follow-up, including immunosuppressive therapy.